Excitation-contraction coupling and mitochondrial energetics

C Maack, B O'Rourke - Basic research in cardiology, 2007 - Springer
Basic research in cardiology, 2007Springer
Cardiac excitation-contraction (EC) coupling consumes vast amounts of cellular energy,
most of which is produced in mitochondria by oxidative phosphorylation. In order to adapt
the constantly varying workload of the heart to energy supply, tight coupling mechanisms are
essential to maintain cellular pools of ATP, phosphocreatine and NADH. To our current
knowledge, the most important regulators of oxidative phosphorylation are ADP, P i, and Ca
2+. However, the kinetics of mitochondrial Ca 2+-uptake during EC coupling are currently a …
Abstract
Cardiac excitation-contraction (EC) coupling consumes vast amounts of cellular energy, most of which is produced in mitochondria by oxidative phosphorylation. In order to adapt the constantly varying workload of the heart to energy supply, tight coupling mechanisms are essential to maintain cellular pools of ATP, phosphocreatine and NADH. To our current knowledge, the most important regulators of oxidative phosphorylation are ADP, Pi, and Ca2+. However, the kinetics of mitochondrial Ca2+-uptake during EC coupling are currently a matter of intense debate. Recent experimental findings suggest the existence of a mitochondrial Ca2+ microdomain in cardiac myocytes, justified by the close proximity of mitochondria to the sites of cellular Ca2+ release, i. e., the ryanodine receptors of the sarcoplasmic reticulum. Such a Ca2+ microdomain could explain seemingly controversial results on mitochondrial Ca2+ uptake kinetics in isolated mitochondria versus whole cardiac myocytes. Another important consideration is that rapid mitochondrial Ca2+ uptake facilitated by microdomains may shape cytosolic Ca2+ signals in cardiac myocytes and have an impact on energy supply and demand matching. Defects in EC coupling in chronic heart failure may adversely affect mitochondrial Ca2+ uptake and energetics, initiating a vicious cycle of contractile dysfunction and energy depletion. Future therapeutic approaches in the treatment of heart failure could be aimed at interrupting this vicious cycle.
Springer